These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 4149128)

  • 1. Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
    Gross GJ; Winbury MM
    J Pharmacol Exp Ther; 1973 Dec; 187(3):451-64. PubMed ID: 4149128
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoregulation of the coronary vascular resistance after beta-adrenergic receptor blockade.
    Gattullo D; Losano G; Vacca G
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):14-9. PubMed ID: 6133526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of beta-blockade on coronary and systemic circulation in dogs at rest and during adaptation to exercise.
    Ehrlich W; Schrijen FV; Krausman DT; Caldini P; Brady JV
    Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):213-27. PubMed ID: 4147879
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of beta-adrenergic blockade on coronary blood flow in the homografted canine heart.
    Boake WC; Folts JD
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):96-104. PubMed ID: 4398413
    [No Abstract]   [Full Text] [Related]  

  • 7. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
    Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
    Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
    [No Abstract]   [Full Text] [Related]  

  • 9. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of pentrinitrol, nitroglycerin and propranolol on small vessel blood content of the canine myocardium.
    Howe BB; Winbury MM
    J Pharmacol Exp Ther; 1973 Dec; 187(3):465-74. PubMed ID: 4770393
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a coronary vasodilating substance, carbocromen, on the coronary blood flow under hypoxia and administration of adrenergic blocking agents.
    Koyama T; Nakagawa K; Marutani Y
    Arzneimittelforschung; 1972 Mar; 22(3):502-7. PubMed ID: 4402602
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of adrenergic stimulation on conductive and resistive segments of the coronary vascular bed.
    Malindzak GS; Kosinski EJ; Green HD; Yarborough GW
    J Pharmacol Exp Ther; 1978 Aug; 206(2):248-58. PubMed ID: 682109
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronary vasodilation and adrenergic receptors.
    Malindzak GS; Miller RD; Green HD
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):87-98. PubMed ID: 4622069
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurogenic influences on the coronary vascular response to ischemia in the awake dog.
    Bache RJ; Cobb FR; Ebert PA; Greenfield JC
    J Thorac Cardiovasc Surg; 1975 Mar; 69(3):421-8. PubMed ID: 1117733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-blockers: redistribution of coronary blood flow and experimental myocardial ischaemia].
    Giudicelli JF; Berdeaux A
    Nouv Presse Med; 1978 Sep; 7(31):2721-5. PubMed ID: 30950
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.